Biotech · Private company
Instylla, Inc.
Track this companyFree. Adds Instylla, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Embrace HES including Instylla™ Delivery Kit and Instylla™ MicrocatheterArterial Bleeding in Solid Organs and Peripheral ArteriesClinicalTrials.gov · fetched Nov 12, 2026
- Instylla HESHypervascular TumorsClinicalTrials.gov · fetched Nov 12, 2026
- TAE or cTACEHypervascular TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- (HALT) Embrace Hydrogel Embolic System (HES) Study of Embolization in Peripheral Arterial BleedsNA · ACTIVE_NOT_RECRUITING · started Dec 12, 2022ClinicalTrials.gov NCT05364502 · fetched Nov 12, 2026
- Instylla HES Hypervascular Tumor Pivotal StudyNA · COMPLETED · started Mar 5, 2021ClinicalTrials.gov NCT04523350 · fetched Nov 12, 2026